As prescription drug prices continue to rise, so does CEO pay. The 25 highest paid CEOs are listed below.
CEO | Company | Total Pay |
Ari Bousbib | Iqvia Holdings | $38,029,517 |
Brenton Saunders | Allergan | $32,827,626 |
Alex Gorsky | Johnson & Johnson | $29,802,564 |
Ian Read | Pfizer Inc | $27,913,775 |
Leonard Schleifer | Regeneron | $26,508,058 |
Richard Gonzalez | Abbvie | $22,625,243 |
Marc Casper | Thermo Fisher | $22,275,176 |
Giovanni Caforio | Bristol Myers Squibb | $18,687,123 |
Howard Robin | Nektar Therapeutics | $18,097,411 |
Kenneth Frazier | Merck | $17,643,087 |
Jeffrey Leiden | Vertex | $17,227,301 |
Robert Bradway | Amgen | $16,899,789 |
Herve Hoppenot | Incyte | $16,087,031 |
Ricks David | Eli Lilly | $15,845,991 |
John Mulligan | Gilead Sciences | $15,438,459 |
Michel Vounatsos | Biogen | $13,664,373 |
Mark Alles | Celgene | $13,115,985 |
Heather Bresch | Mylan | $12,744,397 |
Robert Friel | Perkinelmer | $11,365,597 |
Juan Ramon Alaix | Zoetis | $10,528,769 |
Michael McMullen | Agilent Technologies | $10,090,661 |
Francis Desouza | Illumina | $8,807,716 |
John Hendrickson | Perrigo | $8,322,228 |
Christopher O’Connell | Waters Corp | $7,599,988 |
Oliver Filliol | Mettler Toledo | $7,259,085 |